China NMPA Drug Inspection - Hebei Guorentang Pharmaceutical Co., Ltd. - Bletilla striata
China NMPA drug inspection for Hebei Guorentang Pharmaceutical Co., Ltd. published December 29, 2017. Drug: Bletilla striata. On December 29, 2017, the China Food and Drug Administration (CFDA) announced significant quality control issues followi
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Hebei Guorentang Pharmaceutical Co., Ltd. published December 29, 2017. Drug: Bletilla striata. On December 29, 2017, the China Food and Drug Administration (CFDA) announced significant quality control issues followi
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox